Easy Access and Express Report Delivery Service
Biosimilars & Follow-on-Biologics Market, Global Outlook and Forecast 2024-2030
Report ID
48278
Publisher
Market Monitor Global
Published Date
07-Feb
Delivery Format
PDF
No of Report Page
110
Editor's Rating
-
Report Details
This research report provides a comprehensive analysis of the Biosimilars & Follow-on-Biologics market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Biosimilars & Follow-on-Biologics market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Biosimilars & Follow-on-Biologics, challenges faced by the industry, and potential opportunities for market players. The global Biosimilars & Follow-on-Biologics market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Biosimilars & Follow-on-Biologics market presents opportunities for various stakeholders, including Blood Disorders, Oncology Diseases. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Biosimilars & Follow-on-Biologics market. Additionally, the growing consumer demand present avenues for market expansion. The global Biosimilars & Follow-on-Biologics market was valued at US$ 21210 million in 2023 and is projected to reach US$ 51170 million by 2030, at a CAGR of 15.8% during the forecast period. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Key Features: The research report on the Biosimilars & Follow-on-Biologics market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders. Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Biosimilars & Follow-on-Biologics market. Market Overview: The report provides a comprehensive overview of the Biosimilars & Follow-on-Biologics market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Human Growth Hormone, Erythropoietin), region, and application, highlighting the key drivers, challenges, and opportunities within each segment. Market Dynamics: The report analyses the market dynamics driving the growth and development of the Biosimilars & Follow-on-Biologics market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Biosimilars & Follow-on-Biologics market's trajectory. Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Biosimilars & Follow-on-Biologics market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments. Market Segmentation and Forecast: The report segment the Biosimilars & Follow-on-Biologics market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions. Technological Trends: The report should highlight the key technological trends shaping the Biosimilars & Follow-on-Biologics market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences. Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Biosimilars & Follow-on-Biologics market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders. Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Biosimilars & Follow-on-Biologics, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments. Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Biosimilars & Follow-on-Biologics market. Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts. Market Segmentation Biosimilars & Follow-on-Biologics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value. Market segment by Type Human Growth Hormone Erythropoietin Monoclonal Antibodies Insulin Interferon Granulocyte-Colony Stimulating Factor Peptide Others Market segment by Application Blood Disorders Oncology Diseases Chronic and Autoimmune Diseases Growth Hormone Deficiencies Others Global Biosimilars & Follow-on-Biologics Market Segment Percentages, By Region and Country, 2023 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Major players covered Novartis Synthon Pharmaceuticals Teva Pharmaceutical Industries LG Life Sciences Celltrion Biocon Hospira Merck Group Biogen idec, Inc. Genentech (Roche Group) Outline of Major Chapters: Chapter 1: Introduces the definition of Biosimilars & Follow-on-Biologics, market overview. Chapter 2: Global Biosimilars & Follow-on-Biologics market size in revenue. Chapter 3: Detailed analysis of Biosimilars & Follow-on-Biologics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of Biosimilars & Follow-on-Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: The main points and conclusions of the report. -
Table Of Content
1 Introduction to Research & Analysis Reports 1.1 Biosimilars & Follow-on-Biologics Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Biosimilars & Follow-on-Biologics Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global Biosimilars & Follow-on-Biologics Overall Market Size 2.1 Global Biosimilars & Follow-on-Biologics Market Size: 2023 VS 2030 2.2 Global Biosimilars & Follow-on-Biologics Market Size, Prospects & Forecasts: 2019-2030 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Biosimilars & Follow-on-Biologics Players in Global Market 3.2 Top Global Biosimilars & Follow-on-Biologics Companies Ranked by Revenue 3.3 Global Biosimilars & Follow-on-Biologics Revenue by Companies 3.4 Top 3 and Top 5 Biosimilars & Follow-on-Biologics Companies in Global Market, by Revenue in 2023 3.5 Global Companies Biosimilars & Follow-on-Biologics Product Type 3.6 Tier 1, Tier 2 and Tier 3 Biosimilars & Follow-on-Biologics Players in Global Market 3.6.1 List of Global Tier 1 Biosimilars & Follow-on-Biologics Companies 3.6.2 List of Global Tier 2 and Tier 3 Biosimilars & Follow-on-Biologics Companies 4 Market Sights by Product 4.1 Overview 4.1.1 By Type - Global Biosimilars & Follow-on-Biologics Market Size Markets, 2023 & 2030 4.1.2 Human Growth Hormone 4.1.3 Erythropoietin 4.1.4 Monoclonal Antibodies 4.1.5 Insulin 4.1.6 Interferon 4.1.7 Granulocyte-Colony Stimulating Factor 4.1.8 Peptide 4.1.9 Others 4.2 By Type - Global Biosimilars & Follow-on-Biologics Revenue & Forecasts 4.2.1 By Type - Global Biosimilars & Follow-on-Biologics Revenue, 2019-2024 4.2.2 By Type - Global Biosimilars & Follow-on-Biologics Revenue, 2025-2030 4.2.3 By Type - Global Biosimilars & Follow-on-Biologics Revenue Market Share, 2019-2030 5 Sights by Application 5.1 Overview 5.1.1 By Application - Global Biosimilars & Follow-on-Biologics Market Size, 2023 & 2030 5.1.2 Blood Disorders 5.1.3 Oncology Diseases 5.1.4 Chronic and Autoimmune Diseases 5.1.5 Growth Hormone Deficiencies 5.1.6 Others 5.2 By Application - Global Biosimilars & Follow-on-Biologics Revenue & Forecasts 5.2.1 By Application - Global Biosimilars & Follow-on-Biologics Revenue, 2019-2024 5.2.2 By Application - Global Biosimilars & Follow-on-Biologics Revenue, 2025-2030 5.2.3 By Application - Global Biosimilars & Follow-on-Biologics Revenue Market Share, 2019-2030 6 Sights by Region 6.1 By Region - Global Biosimilars & Follow-on-Biologics Market Size, 2023 & 2030 6.2 By Region - Global Biosimilars & Follow-on-Biologics Revenue & Forecasts 6.2.1 By Region - Global Biosimilars & Follow-on-Biologics Revenue, 2019-2024 6.2.2 By Region - Global Biosimilars & Follow-on-Biologics Revenue, 2025-2030 6.2.3 By Region - Global Biosimilars & Follow-on-Biologics Revenue Market Share, 2019-2030 6.3 North America 6.3.1 By Country - North America Biosimilars & Follow-on-Biologics Revenue, 2019-2030 6.3.2 US Biosimilars & Follow-on-Biologics Market Size, 2019-2030 6.3.3 Canada Biosimilars & Follow-on-Biologics Market Size, 2019-2030 6.3.4 Mexico Biosimilars & Follow-on-Biologics Market Size, 2019-2030 6.4 Europe 6.4.1 By Country - Europe Biosimilars & Follow-on-Biologics Revenue, 2019-2030 6.4.2 Germany Biosimilars & Follow-on-Biologics Market Size, 2019-2030 6.4.3 France Biosimilars & Follow-on-Biologics Market Size, 2019-2030 6.4.4 U.K. Biosimilars & Follow-on-Biologics Market Size, 2019-2030 6.4.5 Italy Biosimilars & Follow-on-Biologics Market Size, 2019-2030 6.4.6 Russia Biosimilars & Follow-on-Biologics Market Size, 2019-2030 6.4.7 Nordic Countries Biosimilars & Follow-on-Biologics Market Size, 2019-2030 6.4.8 Benelux Biosimilars & Follow-on-Biologics Market Size, 2019-2030 6.5 Asia 6.5.1 By Region - Asia Biosimilars & Follow-on-Biologics Revenue, 2019-2030 6.5.2 China Biosimilars & Follow-on-Biologics Market Size, 2019-2030 6.5.3 Japan Biosimilars & Follow-on-Biologics Market Size, 2019-2030 6.5.4 South Korea Biosimilars & Follow-on-Biologics Market Size, 2019-2030 6.5.5 Southeast Asia Biosimilars & Follow-on-Biologics Market Size, 2019-2030 6.5.6 India Biosimilars & Follow-on-Biologics Market Size, 2019-2030 6.6 South America 6.6.1 By Country - South America Biosimilars & Follow-on-Biologics Revenue, 2019-2030 6.6.2 Brazil Biosimilars & Follow-on-Biologics Market Size, 2019-2030 6.6.3 Argentina Biosimilars & Follow-on-Biologics Market Size, 2019-2030 6.7 Middle East & Africa 6.7.1 By Country - Middle East & Africa Biosimilars & Follow-on-Biologics Revenue, 2019-2030 6.7.2 Turkey Biosimilars & Follow-on-Biologics Market Size, 2019-2030 6.7.3 Israel Biosimilars & Follow-on-Biologics Market Size, 2019-2030 6.7.4 Saudi Arabia Biosimilars & Follow-on-Biologics Market Size, 2019-2030 6.7.5 UAE Biosimilars & Follow-on-Biologics Market Size, 2019-2030 7 Biosimilars & Follow-on-Biologics Companies Profiles 7.1 Novartis 7.1.1 Novartis Company Summary 7.1.2 Novartis Business Overview 7.1.3 Novartis Biosimilars & Follow-on-Biologics Major Product Offerings 7.1.4 Novartis Biosimilars & Follow-on-Biologics Revenue in Global Market (2019-2024) 7.1.5 Novartis Key News & Latest Developments 7.2 Synthon Pharmaceuticals 7.2.1 Synthon Pharmaceuticals Company Summary 7.2.2 Synthon Pharmaceuticals Business Overview 7.2.3 Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Major Product Offerings 7.2.4 Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Revenue in Global Market (2019-2024) 7.2.5 Synthon Pharmaceuticals Key News & Latest Developments 7.3 Teva Pharmaceutical Industries 7.3.1 Teva Pharmaceutical Industries Company Summary 7.3.2 Teva Pharmaceutical Industries Business Overview 7.3.3 Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Major Product Offerings 7.3.4 Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Revenue in Global Market (2019-2024) 7.3.5 Teva Pharmaceutical Industries Key News & Latest Developments 7.4 LG Life Sciences 7.4.1 LG Life Sciences Company Summary 7.4.2 LG Life Sciences Business Overview 7.4.3 LG Life Sciences Biosimilars & Follow-on-Biologics Major Product Offerings 7.4.4 LG Life Sciences Biosimilars & Follow-on-Biologics Revenue in Global Market (2019-2024) 7.4.5 LG Life Sciences Key News & Latest Developments 7.5 Celltrion 7.5.1 Celltrion Company Summary 7.5.2 Celltrion Business Overview 7.5.3 Celltrion Biosimilars & Follow-on-Biologics Major Product Offerings 7.5.4 Celltrion Biosimilars & Follow-on-Biologics Revenue in Global Market (2019-2024) 7.5.5 Celltrion Key News & Latest Developments 7.6 Biocon 7.6.1 Biocon Company Summary 7.6.2 Biocon Business Overview 7.6.3 Biocon Biosimilars & Follow-on-Biologics Major Product Offerings 7.6.4 Biocon Biosimilars & Follow-on-Biologics Revenue in Global Market (2019-2024) 7.6.5 Biocon Key News & Latest Developments 7.7 Hospira 7.7.1 Hospira Company Summary 7.7.2 Hospira Business Overview 7.7.3 Hospira Biosimilars & Follow-on-Biologics Major Product Offerings 7.7.4 Hospira Biosimilars & Follow-on-Biologics Revenue in Global Market (2019-2024) 7.7.5 Hospira Key News & Latest Developments 7.8 Merck Group 7.8.1 Merck Group Company Summary 7.8.2 Merck Group Business Overview 7.8.3 Merck Group Biosimilars & Follow-on-Biologics Major Product Offerings 7.8.4 Merck Group Biosimilars & Follow-on-Biologics Revenue in Global Market (2019-2024) 7.8.5 Merck Group Key News & Latest Developments 7.9 Biogen idec, Inc. 7.9.1 Biogen idec, Inc. Company Summary 7.9.2 Biogen idec, Inc. Business Overview 7.9.3 Biogen idec, Inc. Biosimilars & Follow-on-Biologics Major Product Offerings 7.9.4 Biogen idec, Inc. Biosimilars & Follow-on-Biologics Revenue in Global Market (2019-2024) 7.9.5 Biogen idec, Inc. Key News & Latest Developments 7.10 Genentech (Roche Group) 7.10.1 Genentech (Roche Group) Company Summary 7.10.2 Genentech (Roche Group) Business Overview 7.10.3 Genentech (Roche Group) Biosimilars & Follow-on-Biologics Major Product Offerings 7.10.4 Genentech (Roche Group) Biosimilars & Follow-on-Biologics Revenue in Global Market (2019-2024) 7.10.5 Genentech (Roche Group) Key News & Latest Developments 8 Conclusion 9 Appendix 9.1 Note 9.2 Examples of Clients 9.3 Disclaimer -
Inquiry Before Buying
WHY CHOOSE US
Discover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday -
Request Sample
WHY CHOOSE US
Easy Access and Express Report Delivery ServiceDiscover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday
